Therapy of Early Chronic Phase CML With Gleevec

Clinical trial NCT00048672 · COMPLETED

Trial details

NCT number: NCT00048672
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic-Phase

Start date: 2001-03-01
Primary completion: 2002-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.